Yes, but we have to wait to see if it all turns as rosy as it appears.
Questions:
1. Can Rethink My Healthcare truly sell 2M test kits/week?
2. How many of their customers will order test kits through them?
3. How much has been put into the "Escrow account"?
On the upside, if they truly ordered 2 million test kits and had to pay upfront or even a significant amount, that would indicate a lot of cash has been deposited.
If the 2M kits arrive and move out and they issue follow up PR that another order(s) is on the way, then I think stock will climb and hold price.
Lots of selling today across COVID-19 related stocks, some because of news that many test kits on market don't work well, some because of optimism that infection rate is declining, some because market is down etc...
Should WORX land and hold a 25% capacity of the Australian manufacturer of these test kits and order a steady stream because they have established themselves as a reliable distributor, don't know what price this rises to.
GLTA
AIMO
News 
Market Data 
Discover 
AI
